TELO GENOMICS CORP (TELO.CA) Stock Price & Overview
TSX-V:TELO • CA87975M2085
The current stock price of TELO.CA is 0.05 CAD. Today TELO.CA is down by 0%. In the past month the price increased by 11.11%. In the past year, price decreased by -66.67%.
TELO.CA Key Statistics
- Market Cap
- 5.022M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.03
- Dividend Yield
- N/A
TELO.CA Stock Performance
TELO.CA Stock Chart
TELO.CA Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to TELO.CA. When comparing the yearly performance of all stocks, TELO.CA is a bad performer in the overall market: 95.68% of all stocks are doing better.
TELO.CA Earnings
TELO.CA Forecast & Estimates
TELO.CA Groups
Sector & Classification
TELO.CA Financial Highlights
Over the last trailing twelve months TELO.CA reported a non-GAAP Earnings per Share(EPS) of -0.03. The EPS increased by 19.72% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -446.15% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
TELO.CA Ownership
TELO.CA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| EPRX | EUPRAXIA PHARMACEUTICALS INC | N/A | 573.418M | ||
| EDT | SPECTRAL MEDICAL INC | N/A | 386.179M | ||
| HBP | HELIX BIOPHARMA CORP | N/A | 160.398M | ||
| MDNA | MEDICENNA THERAPEUTICS CORP | N/A | 72.567M | ||
| COV | COVALON TECHNOLOGIES LTD | 13.04 | 51.926M | ||
| BCT | BRIACELL THERAPEUTICS CORP | N/A | 39.875M | ||
| RVX | RESVERLOGIX CORP | N/A | 34.507M | ||
| MBX | MICROBIX BIOSYSTEMS INC | 5.94 | 33.252M | ||
| HEM | HEMOSTEMIX INC | N/A | 15.62M | ||
| MPH | MEDICURE INC | N/A | 11.693M | ||
| CSCI | COSCIENS BIOPHARMA INC | N/A | 6.996M | ||
| KNE | KANE BIOTECH INC | N/A | 6.356M | ||
| QPT | QUEST PHARMATECH INC | N/A | 5.074M |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the TSX Venture Exchange Exchange | Find stocks with similar TA and Setup ratings on the Canadian exchanges | Find stocks with similar Fundamental rating on the Canadian exchanges | Find the competitors with the best technical ratings on the Canadian exchanges | Find the competitors with the best fundamentals on the Canadian exchanges | Find the competitors with the best valuation on the Canadian exchanges | Find the competitors with the best dividend on the Canadian exchanges | Find the competitors with the best analyst ratings on the Canadian exchanges
About TELO.CA
Company Profile
Telo Genomics Corp. is a molecular diagnostics company, which engages in the development of telomere analysis platforms in the industry. The company is headquartered in Toronto, Ontario. The company went IPO on 2012-02-15. Its technologies utilize a multi-step process that involves capturing sample cells from blood or tissue, labeling, 3D formatting, processing and analyzing with TeloView. Its technologies are based on single cell biology. TeloView is a software platform, which is used to quantify specific features of each patient’s telomeres. The company quantifies six specific biological and structural features of telomeres and builds a score for each patient to assess their risk of disease progression and potential treatment response. TeloView helps in capturing the heterogeneity and complexity of cancers with relatively small sample sizes in clinical studies. Its initial lead includes multiple myeloma, prostate cancer and Alzheimer's disease.
Company Info
TELO GENOMICS CORP
Mars Centre, 101 College St Suite 200
TORONTO ONTARIO M5G 1L7 CA
CEO: Sherif Louis
Employees: 0
Phone: 14166738487
TELO GENOMICS CORP / TELO.CA FAQ
Can you describe the business of TELO GENOMICS CORP?
Telo Genomics Corp. is a molecular diagnostics company, which engages in the development of telomere analysis platforms in the industry. The company is headquartered in Toronto, Ontario. The company went IPO on 2012-02-15. Its technologies utilize a multi-step process that involves capturing sample cells from blood or tissue, labeling, 3D formatting, processing and analyzing with TeloView. Its technologies are based on single cell biology. TeloView is a software platform, which is used to quantify specific features of each patient’s telomeres. The company quantifies six specific biological and structural features of telomeres and builds a score for each patient to assess their risk of disease progression and potential treatment response. TeloView helps in capturing the heterogeneity and complexity of cancers with relatively small sample sizes in clinical studies. Its initial lead includes multiple myeloma, prostate cancer and Alzheimer's disease.
What is the stock price of TELO GENOMICS CORP today?
The current stock price of TELO.CA is 0.05 CAD.
Does TELO stock pay dividends?
TELO.CA does not pay a dividend.
What is the ChartMill technical and fundamental rating of TELO stock?
TELO.CA has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
What is the employee count for TELO stock?
TELO GENOMICS CORP (TELO.CA) currently has 0 employees.
When does TELO GENOMICS CORP (TELO.CA) report earnings?
TELO GENOMICS CORP (TELO.CA) will report earnings on 2026-03-03.
What is the ownership structure of TELO GENOMICS CORP (TELO.CA)?
You can find the ownership structure of TELO GENOMICS CORP (TELO.CA) on the Ownership tab.